AWHL

$0.23+9.68%

Aspira Women's Health Inc.

Market Cap

$11M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

2.04

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

1.2

TTM to Jun 2026 · revenue

Flagged input, hover for details

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	2,305	2,228	1,967	2,046	8,546
Cost of revenue	922	790	896	915	3,523
Gross profit	1,383	1,438	1,071	1,131	5,023
Research & development	739	462	1,226	692	3,119
Total operating expenses	2,962	2,722	3,274	2,966	11,924
Operating income	(1,579)	(1,284)	(2,203)	(1,835)	(6,901)
Pretax income			676
Net income	(4,892)	(3,369)	676	(2,420)	(10,005)
EPS (basic) ($)	(0.13)		0.02	(0.05)	—
EPS (diluted) ($)	(0.13)		(0.05)	(0.05)	—
Weighted avg. shares (basic)	36,388		43,492	44,250
Weighted avg. shares (diluted)	36,388		45,774	44,250

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

13 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jul 15, 2026 accepted 8:12 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Jul 7, 2026 accepted 8:32 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Jun 22, 2026 accepted 1:13 PM ET	5.02Officer / director change	Document SEC ↗
Jun 17, 2026 accepted 8:28 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 9, 2026 accepted 11:48 AM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
May 26, 2026 accepted 1:03 PM ET	1.01Material agreement	Document SEC ↗
Apr 30, 2026 accepted 8:56 PM ET	5.02Officer / director change	Document SEC ↗
Mar 25, 2026 accepted 8:41 PM ET	8-K/A 1.01Material agreement	Document SEC ↗
Jan 30, 2026 accepted 10:16 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Dec 31, 2025 accepted 12:00 PM ET	7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

Aspira Women's Health Inc. (AWHL) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada · 2026-10-30

AWHL 8-K/A & SEC Filings

Yahoo Finance Australia · 2026-10-23

Vaso Stock Surges 149% in a Year: What's Behind the Rally?

Yahoo · 2026-10-16

Vaso Gains More Than 65% in Three Months: What's Driving the Stock?

TradingView · 2026-09-08

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?

Yahoo Finance · 2026-07-17

Zacks Initiates Coverage of Aspira With Neutral Recommendation

Yahoo Finance · 2026-06-16

Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health

Yahoo Finance · 2026-05-26

Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)

Yahoo Finance · 2026-04-23

The Oncology Institute Names Minh Merchant Chief Legal Officer

Yahoo Finance · 2026-04-06

Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance · 2025-11-14

Aspira Women's Health Inc. (AWHL) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2025-06-30

A growing portfolio of health and wellness alternatives

The Business Times · 2022-12-08

Nancy G Cocozza Net Worth (2026)

GuruFocus · 2022-09-27

Informational purposes only, not investment advice.

Corporate Events (8-K)

13 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jul 15, 2026 accepted 8:12 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Jul 7, 2026 accepted 8:32 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Jun 22, 2026 accepted 1:13 PM ET	5.02Officer / director change	Document SEC ↗
Jun 17, 2026 accepted 8:28 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 9, 2026 accepted 11:48 AM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
May 26, 2026 accepted 1:03 PM ET	1.01Material agreement	Document SEC ↗
Apr 30, 2026 accepted 8:56 PM ET	5.02Officer / director change	Document SEC ↗
Mar 25, 2026 accepted 8:41 PM ET	8-K/A 1.01Material agreement	Document SEC ↗
Jan 30, 2026 accepted 10:16 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Dec 31, 2025 accepted 12:00 PM ET	7.01Reg FD disclosure	Document SEC ↗